Locarnini SA - Search Results

1

Mechanisms of drug resistance and novel approaches to therapy for chronic hepatitis C.

Locarnini SA. Locarnini SA. J Gastroenterol Hepatol. 2002 Dec;17 Suppl 3:S351-9. doi: 10.1046/j.1440-1746.17.s3.27.x. J Gastroenterol Hepatol. 2002. PMID: 12472963 Review.

2

Evolving therapies for the treatment of chronic hepatitis B virus infection.

Delaney W 4th, Bartholomeusz A, Locarnini SA. Delaney W 4th, et al. Among authors: locarnini sa. Expert Opin Investig Drugs. 2002 Feb;11(2):169-87. doi: 10.1517/13543784.11.2.169. Expert Opin Investig Drugs. 2002. PMID: 11829711 Review.

3

Advances in hepatitis C: what is coming in the next 5 years?

Locarnini SA, Bartholomeusz A. Locarnini SA, et al. J Gastroenterol Hepatol. 2002 Apr;17(4):442-7. doi: 10.1046/j.1440-1746.2002.02768.x. J Gastroenterol Hepatol. 2002. PMID: 11982725 Review.

4

Clinical relevance of viral dynamics and genotypes in hepatitis B virus.

Locarnini SA. Locarnini SA. J Gastroenterol Hepatol. 2002 Dec;17 Suppl 3:S322-8. doi: 10.1046/j.1440-1746.17.s3.21.x. J Gastroenterol Hepatol. 2002. PMID: 12472957 Review.

5

Effect of the G1896A precore mutation on drug sensitivity and replication yield of lamivudine-resistant HBV in vitro.

Chen RY, Edwards R, Shaw T, Colledge D, Delaney WE 4th, Isom H, Bowden S, Desmond P, Locarnini SA. Chen RY, et al. Among authors: locarnini sa. Hepatology. 2003 Jan;37(1):27-35. doi: 10.1053/jhep.2003.50012. Hepatology. 2003. PMID: 12500185

6

Emerging therapies of hepatitis B and C.

Chen RY, Desmond PV, Locarnini SA. Chen RY, et al. Among authors: locarnini sa. J Gastroenterol Hepatol. 2002 Dec;17 Suppl:S471-81. doi: 10.1046/j.1440-1746.17.s4.13.x. J Gastroenterol Hepatol. 2002. PMID: 12534781 Review. No abstract available.

7

Effects of interferon alpha therapy on the catalytic domains of the polymerase gene and basal core promoter, precore and core regions of hepatitis B virus.

Chen RY, Bowden S, Desmond PV, Dean J, Locarnini SA. Chen RY, et al. Among authors: locarnini sa. J Gastroenterol Hepatol. 2003 Jun;18(6):630-7. doi: 10.1046/j.1440-1746.2003.03019.x. J Gastroenterol Hepatol. 2003. PMID: 12753143

8

Interpretation and application of virological testing including resistance in chronic hepatitis B.

Locarnini S. Locarnini S. Med J Malaysia. 2005 Jul;60 Suppl B:41-51. Med J Malaysia. 2005. PMID: 16108173 Review. No abstract available.

9

Antiviral drug resistance: clinical consequences and molecular aspects.

Bartholomeusz A, Locarnini SA. Bartholomeusz A, et al. Among authors: locarnini sa. Semin Liver Dis. 2006 May;26(2):162-70. doi: 10.1055/s-2006-939758. Semin Liver Dis. 2006. PMID: 16673294 Review.

10

SeqHepB: a sequence analysis program and relational database system for chronic hepatitis B.

Yuen LK, Ayres A, Littlejohn M, Colledge D, Edgely A, Maskill WJ, Locarnini SA, Bartholomeusz A. Yuen LK, et al. Among authors: locarnini sa. Antiviral Res. 2007 Jul;75(1):64-74. doi: 10.1016/j.antiviral.2006.11.014. Epub 2006 Dec 22. Antiviral Res. 2007. PMID: 17215050

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

158 results

Search Page